Stay informed with the latest updates for the inheritable blood disorders community. Medical Update for the Hemophilia CommunitySep 12, 2022 Medical Virtual Grand Round Series to Focus on Hemophilia Gene TherapySep 12, 2022 Industry FDA Grants Priority Review for Sanofi’s BIVV001Sep 6, 2022 Industry Rare Factor X Deficiency Survey Shows Disparity in Care Sep 1, 2022 Industry BioMarin Receives Conditional Approval in Europe for Gene TherapyAug 25, 2022 Medical PPTA Posts Statement on Monkeypox and Plasma Protein TherapiesAug 22, 2022 Industry BioMarin Presents Abstract on Vector DNA Transmission Risk at ISTHAug 4, 2022 Industry New Prophylaxis Approval for REBINYN®Aug 3, 2022 Industry Sanofi Provides Fitusiran Trial Updates at ISTHJul 25, 2022 Industry Prophylactic Therapy for Glanzmann Thrombasthenia Moves Towards…Jul 22, 2022 Industry Sanofi and Sobi® Report Progress with BIVV001 at International Congress Jul 20, 2022 Medical New Genotyping Recommendations Issued by MASACJul 15, 2022 Medical National Hemophilia Foundation…Jul 8, 2022 Medical DESMOPRESSIN UPDATE: NOTICE TO PATIENTS – INCORRECT EXPIRATION DATE…Jun 28, 2022 Medical Novel Pilot Program to Focus on Genetic Diseases and Precision Medicine Jun 17, 2022 Pagination First page Previous page Page 1 Page 2 Page 3 Page 4 Current page 5 Page 6 Page 7 Page 8 Page 9 … Next page Last page